IRF1 was identified as a direct target of microRNA (miR)-130b in mesangial cells in the kidney, and inhibiting IRF1 through miR-130b overexpression in NZB/W F1 lupus mice reduced IFN-accelerated nephritis progression, demonstrated by decreased proteinuria and glomerular lesions [25]. This evidence concerns the gene IRF1 and nephritis.